Transdermal opioid patches are increasingly used for management of pain but inappropriate use has contributed to adverse events in various settings.

The Controlled Drugs Accountable Officers Network have issued the following report for practitioners who prescribe, dispense and administer transdermal fentanyl or buprenorphine.